Feasibility and Outcomes of Allogeneic HCT Compared to Chemotherapy in Older AML Patients
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Mohamed Sorror, MD, MSc
Associate Member, Fred Hutch; Associate Professor of Medicine, UW
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Stanford Cancer Institute
Stanford, California, United States
- Northwestern Memorial Hospital
Chicago, Illinois, United States
- University of Maryland
Baltimore, Maryland, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- the John Theurer Cancer Center at Hackensack University Medical Center
Hackensack, New Jersey, United States
- Roswell Park Cancer Institute
Buffalo, New York, United States
- Duke University
Durham, North Carolina, United States
- Cleveland Clinic
Cleveland, Ohio, United States
- University of Pennsylvania Abramson Cancer Center
Philadelphia, Pennsylvania, United States
- University of Utah Huntsman Cancer Institute
Salt Lake City, Utah, United States
- Fred Hutchinson Cancer Research Center
Seattle, Washington, United States
- Scca Network Clinics
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 19 Jul 2013
- Primary completion
- 4 Dec 2018
- Completion
- 4 Dec 2018
- Last update posted
- 15 Nov 2019
- Registered enrollment
- 703
- Registry id
- NCT01929408
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.